Monday, August 22, 2016 11:23:07 AM
Haven't heard about BIIB getting into
lubricants. Do you have any data?
I don't recall the Amyris & Biogen relationship being about lubricants. What is big about this relationship and the biopharmaceutical sector is the use of proteins ... and in that field, proteins are used for "everything" .
From The CC & August 3rd PR
<< The Biogen partnership is one of the most exciting projects we have in our portfolio, and it has the ability to make a transformative change to the biopharmaceutical sector.
The project is focused on using Amyris's advanced microbe engineering technology to evaluate and develop multiple host microorganisms as alternatives to mammalian cell lines for the production of therapeutic recombinant proteins.
What this means is that our partner would be able to employ a more efficient production process using our engineered organisms versus using cells from mammals in their R&D and production efforts.
When successful this could be a game-changing development when it comes to the effective and more efficient production of biopharmaceuticals.
Biogen will fully fund this project with the first phase expected to be completed within 12 months. >>
Just so you know . . .
There is huge money in this sector that is currently very interested in revamping obsolete processes, and implementing newer up-to-date technologies for the management of future costs and competition.
EOM
Recent AMRSQ News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:39 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 02/10/2024 02:24:29 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 02/10/2024 02:14:56 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:42:49 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/14/2023 09:34:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 10:23:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:43:26 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM